[go: up one dir, main page]

MX2019013267A - Proceso para una purificacion eficaz de oligosacaridos de leche humana (olh) neutros a partir de fermentacion microbiana. - Google Patents

Proceso para una purificacion eficaz de oligosacaridos de leche humana (olh) neutros a partir de fermentacion microbiana.

Info

Publication number
MX2019013267A
MX2019013267A MX2019013267A MX2019013267A MX2019013267A MX 2019013267 A MX2019013267 A MX 2019013267A MX 2019013267 A MX2019013267 A MX 2019013267A MX 2019013267 A MX2019013267 A MX 2019013267A MX 2019013267 A MX2019013267 A MX 2019013267A
Authority
MX
Mexico
Prior art keywords
olh
neutral
purification
human milk
microbial fermentation
Prior art date
Application number
MX2019013267A
Other languages
English (en)
Other versions
MX394692B (es
Inventor
Jennewein Stefan
Original Assignee
Jennewein Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49949589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2019013267(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jennewein Biotechnologie Gmbh filed Critical Jennewein Biotechnologie Gmbh
Publication of MX2019013267A publication Critical patent/MX2019013267A/es
Publication of MX394692B publication Critical patent/MX394692B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Feed For Specific Animals (AREA)

Abstract

La presente solicitud desvela un proceso sencillo para la purificación de oligosacáridos de leche humana (OLH) neutros producidos por fermentación microbiana. El proceso utiliza una combinación de una etapa de tratamiento intercambiador iónico catiónico, tratamiento intercambiador iónico aniónico una etapa de nanofiltración y/o electrodiálisis, que permite la purificación eficaz de grandes cantidades de OLH neutros, a elevada pureza. Contrariamente a la purificación utilizada actualmente en la producción fermentativa de OLH neutros, el proceso expuesto permite proporcionar OLH sin la necesidad de una separación cromatográfica. De esta manera, los OLH purificados pueden obtenerse en forma sólida mediante secado por pulverización, como material cristalino o como concentrado filtrado estéril. Los OLH proporcionados están libres de proteínas y de material recombinante procedente de las cepas microbianas recombinantes utilizadas y por consiguiente resultan muy apropiados para su uso en alimentos, fórmulas médicas y aplicaciones alimentarias (p. ej., alimento para mascotas).
MX2019013267A 2014-01-20 2014-12-23 Proceso para una purificación eficaz de oligosacáridos de leche humana (olh) neutros a partir de fermentación microbiana. MX394692B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14151737.5A EP2896628B1 (en) 2014-01-20 2014-01-20 Process for efficient purification of neutral human milk oligosaccharides (HMOs) from microbial fermentation
PCT/EP2014/079212 WO2015106943A1 (en) 2014-01-20 2014-12-23 PROCESS FOR EFFICIENT PURIFICATION OF NEUTRAL HUMAN MILK OLIGOSACCHARIDES (HMOs) FROM MICROBIAL FERMENTATION

Publications (2)

Publication Number Publication Date
MX2019013267A true MX2019013267A (es) 2020-01-13
MX394692B MX394692B (es) 2025-03-24

Family

ID=49949589

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019013267A MX394692B (es) 2014-01-20 2014-12-23 Proceso para una purificación eficaz de oligosacáridos de leche humana (olh) neutros a partir de fermentación microbiana.
MX2016009394A MX369375B (es) 2014-01-20 2014-12-23 Proceso para una purificacion eficaz de oligosacaridos de leche humana (olh) neutros a partir de fermentacion microbiana.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2016009394A MX369375B (es) 2014-01-20 2014-12-23 Proceso para una purificacion eficaz de oligosacaridos de leche humana (olh) neutros a partir de fermentacion microbiana.

Country Status (18)

Country Link
US (4) US10377787B2 (es)
EP (5) EP2896628B1 (es)
JP (2) JP6901857B2 (es)
KR (1) KR102137027B1 (es)
CN (1) CN106132977B (es)
AT (2) AT17418U1 (es)
AU (1) AU2014377374B2 (es)
BR (1) BR112016016705A8 (es)
CZ (2) CZ35289U1 (es)
DE (2) DE202014011399U1 (es)
DK (6) DK2896628T3 (es)
ES (4) ES2701163T3 (es)
FI (2) FI3680249T3 (es)
MX (2) MX394692B (es)
PH (2) PH12016501421B1 (es)
PL (4) PL2896628T3 (es)
RU (1) RU2682445C2 (es)
WO (1) WO2015106943A1 (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2701163T3 (es) 2014-01-20 2019-02-21 Jennewein Biotechnologie Gmbh Procedimiento para la purificación eficiente de oligosacáridos de la leche humana (HMO) neutros a partir de la fermentación microbiana
EP3227309B1 (en) * 2014-12-05 2025-09-24 Glycom A/S Crystalline difucosyllactose
EP3141610A1 (en) 2015-09-12 2017-03-15 Jennewein Biotechnologie GmbH Production of human milk oligosaccharides in microbial hosts with engineered import / export
US10829508B2 (en) 2015-12-18 2020-11-10 Glycom A/S Fermentative production of oligosaccharides
ES2991621T3 (es) * 2016-03-07 2024-12-04 Glycom As Separación de oligosacáridos de caldo de fermentación
DE202017007248U1 (de) 2016-04-19 2020-04-23 Glycom A/S Abtrennung von Oligosacchariden aus der Fermentationsbrühe
WO2019003135A1 (en) 2017-06-30 2019-01-03 Glycom A/S PURIFICATION OF OLIGOSACCHARIDES
WO2019012461A1 (en) 2017-07-12 2019-01-17 Glycom A/S AMORPHOUS MIXTURE COMPRISING A NEUTRAL MONO- OR OLIGOSACCHARIDE AND A NON-GLUCIDIC ACID COMPONENT
EP3450443A1 (en) * 2017-08-29 2019-03-06 Jennewein Biotechnologie GmbH Process for purifying sialylated oligosaccharides
CA3073332A1 (en) 2017-09-29 2019-04-04 Frieslandcampina Nederland B.V. Process for the purification of a neutral human milk oligosaccharide (hmo) from microbial fermentation
EP3486326A1 (en) * 2017-11-21 2019-05-22 Jennewein Biotechnologie GmbH Method for the purification of n-acetylneuraminic acid from a fermentation broth
PL3494805T3 (pl) 2017-12-08 2025-10-06 Chr. Hansen HMO GmbH Suszone rozpyłowo tetrasacharydy
EP3494807A1 (en) 2017-12-11 2019-06-12 Jennewein Biotechnologie GmbH Spray-dried sialyllactose
ES3039971T3 (en) 2017-12-08 2025-10-28 Chr Hansen Hmo Gmbh Spray-dried 3-fucosyllactose
JP2021505174A (ja) 2017-12-08 2021-02-18 イェンネワイン バイオテクノロジー ゲーエムベーハーＪｅｎｎｅｗｅｉｎ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅ ＧｍｂＨ 噴霧乾燥ラクト−ｎ−フコペンタオース
EP3494806B1 (en) 2017-12-08 2025-08-06 Chr. Hansen HMO GmbH Spray-dried lacto-n-fucopentaose
ES3026362T3 (en) * 2018-02-08 2025-06-11 Chr Hansen Hmo Gmbh Spray-dried mixture of human milk oligosaccharides
EP3546060A1 (en) * 2018-03-27 2019-10-02 DuPont Nutrition Biosciences ApS Process for spray drying fucosyllactose solutions and related product compositions
AU2019264788B8 (en) * 2018-05-07 2023-07-27 Chr. Hansen HMO GmbH A simple method for the purification of lacto-N-Neotetraose (LNnT) From Carbohydrates Obtained By Microbial Fermentation
WO2019226431A1 (en) * 2018-05-23 2019-11-28 Dsm Ip Assets B.V. Production of oligosaccharides
ES2933959T3 (es) * 2018-06-01 2023-02-15 Chr Hansen Hmo Gmbh Un método simple para la purificación de una sialil-lactosa
CN109111043B (zh) * 2018-09-16 2021-11-09 苏州渭中科技发展有限公司 一种高盐高cod废水的处理方法
AU2019409513B2 (en) 2018-12-19 2025-12-11 Basf Se Method for separating biomass from a solution comprising biomass and at least one oligosaccaride
EP3914602A4 (en) * 2019-01-21 2022-12-07 DuPont Nutrition Biosciences ApS PROCESS FOR MANUFACTURING L-FUCOSE
EP3686210A1 (en) * 2019-01-24 2020-07-29 DuPont Nutrition Biosciences ApS Process for purifying a human milk oligosaccharide and related compositions
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
US20220022515A1 (en) 2019-02-25 2022-01-27 Nutribam Bv Composition, Food Supplement and Method for Supporting and/or Improving Intestinal Health
EP3741770A1 (en) * 2019-05-21 2020-11-25 Jennewein Biotechnologie GmbH Purification of oligosaccharides from a fermentation broth by using filtration
BR112021015771A2 (pt) * 2019-06-04 2022-01-04 Nutricia Nv Composição nutricional para lactentes ou crianças de primeira infância e uso da composição nutricional
EP3750902A1 (en) 2019-06-14 2020-12-16 Jennewein Biotechnologie GmbH Process for the purification of lacto-n-neotetraose
ES3041027T3 (en) 2019-09-04 2025-11-06 Inbiose Nv Process for removing an antifoam agent from a solution comprising a human milk oligosaccharide and related compositions
EP3822282A1 (en) * 2019-11-18 2021-05-19 DuPont Nutrition Biosciences ApS Process for removing an antifoam agent from a solution comprising a human milk oligosaccharide and related compositions
US12364721B2 (en) 2019-09-24 2025-07-22 Prolacta Bioscience, Inc. Compositions and methods for treatment of inflammatory and immune diseases
JP2023514026A (ja) * 2020-01-29 2023-04-05 ディーエスエム アイピー アセッツ ビー．ブイ． ヒトミルクオリゴ糖を回収して精製する方法
CN111540125B (zh) * 2020-04-20 2021-01-05 中国人民解放军火箭军工程设计研究院 一种充电桩的充电管理方法、设备及计算机可读存储介质
CA3181721A1 (en) * 2020-06-12 2021-12-16 Johan Fredrik Billing Improved demineralization of fermentation broths and purification of fine chemicals such as oligosaccharides
BR112023002758A2 (pt) 2020-08-14 2023-05-02 Prolacta Bioscience Inc Composições de oligossacarídeos de leite humano para uso com bacterioterapias
CN112568439A (zh) * 2020-12-21 2021-03-30 湖北福星生物科技有限公司 一种从微生物发酵液中分离纯化母乳低聚糖的方法及其应用
JP2024502629A (ja) 2021-01-12 2024-01-22 プロラクタ バイオサイエンス，インコーポレイテッド シンバイオティック治療レジメン
CN112920234B (zh) * 2021-01-27 2022-03-29 南开大学 一种2′-岩藻糖基乳糖的富集纯化方法
US20240349770A1 (en) * 2021-04-30 2024-10-24 Dsm Ip Assets B.V. Infant formula with low level of arsenic
DK181242B1 (en) 2021-05-17 2023-05-30 Dsm Ip Assets Bv GENETICALLY ENGINEERED CELLS COMPRISING A RECOMBINANT NUCLEIC ACID SEQUNCE ENCODING AN α-1,2-FUCOSYLTRANSFERASE CAPABLE OF PRODUCING LNFP-I, NUCLEIC ACID SEQUENCES ENCODING SAME AND METHODS FOR USE OF SAME
US20240286081A1 (en) 2021-06-15 2024-08-29 Dsm Ip Assets B.V. Separation of human milk oligosaccharides from a fermentation broth
US20240287116A1 (en) 2021-06-15 2024-08-29 Dsm Ip Assets B.V. Separation of human milk oligosaccharides from a fermentation broth
WO2022263406A1 (en) 2021-06-15 2022-12-22 Dsm Ip Assets B.V. Separation of human milk oligosaccharides from a fermentation broth
WO2022263425A1 (en) 2021-06-15 2022-12-22 Dsm Ip Assets B.V. Separation of human milk oligosaccharides from a fermentation broth
EP4418878A1 (en) 2021-10-18 2024-08-28 DSM IP Assets B.V. A method for providing an amorphous hmo product by drying
CN114539433B (zh) * 2021-12-29 2022-11-01 北京三元食品股份有限公司 一种乳低聚糖的制备方法及制备的低聚糖粉、食品
EP4502168A1 (en) * 2022-03-25 2025-02-05 Kirin Holdings Kabushiki Kaisha Production method for lactodifucotetraose (ldft)
CN117003803A (zh) * 2022-05-07 2023-11-07 山东恒鲁生物科技有限公司 一种三糖的新晶型
CN115873051B (zh) * 2022-05-17 2024-06-25 山东恒鲁生物科技有限公司 三糖的新晶型
CN119403613A (zh) 2022-06-14 2025-02-07 帝斯曼知识产权资产管理有限公司 从发酵液中分离人乳寡糖
WO2024047096A1 (en) 2022-08-30 2024-03-07 Inbiose N.V. Process for purification of an oligosaccharide
WO2024130119A2 (en) 2022-12-16 2024-06-20 Prolacta Bioscience, Inc. Synbiotic compositions for short chain fatty acid production
CN115651039A (zh) * 2022-12-27 2023-01-31 保龄宝生物股份有限公司 一种高密度2’-岩藻糖基乳糖的生产方法
CN116425810B (zh) * 2023-06-14 2023-08-11 山东合成远景生物科技有限公司 一种混合液中3-岩藻糖基乳糖的纯化方法
CN117089503B (zh) 2023-10-17 2024-01-02 保龄宝生物股份有限公司 一种大肠杆菌k-12 mg1655 blbyzt6及其应用
WO2025114343A2 (en) * 2023-11-29 2025-06-05 Frieslandcampina Nederland B.V. Process for the production of human milk oligosaccharides

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61271296A (ja) 1985-05-28 1986-12-01 Kyogyo Kumiai N F I Ｎ−アセチルキトオリゴ糖の製造方法
JPH0614870B2 (ja) * 1986-12-15 1994-03-02 株式会社ヤクルト本社 ガラクトオリゴ糖の製造法
NZ335203A (en) 1996-10-10 2000-10-27 Neose Technologies Inc Carbohydrate, purification using ultrafiltration, reverse osmosis and nanofiltration
US5945314A (en) 1997-03-31 1999-08-31 Abbott Laboratories Process for synthesizing oligosaccharides
US6323008B1 (en) 1997-08-14 2001-11-27 Neose Technologies, Inc. Methods for producing sialyloligosaccharides in a dairy source
US6017433A (en) 1997-11-12 2000-01-25 Archer Daniels Midland Company Desalting aqueous streams via filled cell electrodialysis
AU1234400A (en) 1998-10-27 2000-05-15 Cargill Incorporated Method for purifying a polyol product stream
DE19906865C2 (de) 1999-02-18 2003-03-13 Infineon Technologies Ag Verfahren und Einrichtung zur Entzerrung und Decodierung eines Datensignals
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
FR2799754A1 (fr) 1999-10-18 2001-04-20 Roquette Freres Procede de separation et de purification d'acide lactique a partir d'un milieu de fermentation
US6288222B1 (en) 2000-02-16 2001-09-11 Neose Technologies, Inc. Method of filtration of a dairy stream
US6618584B1 (en) 2000-08-30 2003-09-09 Telefonaktiebolaget Lm Ericsson (Publ) Terminal authentication procedure timing for data calls
JP2003047402A (ja) * 2001-08-06 2003-02-18 Meiji Milk Prod Co Ltd 中性オリゴ糖含有育児用調製乳
JP2003048901A (ja) 2001-08-09 2003-02-21 Oji Paper Co Ltd 長鎖キシロオリゴ糖組成物およびその製造方法
FR2844209B1 (fr) 2002-09-06 2007-10-19 Applexion Ste Nouvelle De Rech Procede de purification par nanofiltration d'une solution aqueuse sucree contenant des anions et cations monovalents et polyvalents
CA2522928C (en) 2003-05-06 2013-09-24 E.I. Du Pont De Nemours And Company Purification of biologically-produced 1,3-propanediol
DK1644482T4 (da) 2003-06-30 2014-12-15 Clasado Inc Hidtil ukendt galactooligosaccharidpræparat og fremstillingen deraf
US20080145899A1 (en) 2004-09-17 2008-06-19 Neose Technologies Inc Production of Oligosaccharides By Microorganisms
CA2580529A1 (en) * 2004-10-01 2006-04-13 Eisai R & D Management Co., Ltd. Fine particle-containing composition and manufacturing method therefor
WO2006084719A1 (en) 2005-02-11 2006-08-17 Dsm Ip Assets B.V. Fermentive vitamin c production
US20070256936A1 (en) 2006-05-04 2007-11-08 Robert Jansen Method for Deashing Syrup by Electrodialysis
JPWO2009008362A1 (ja) 2007-07-12 2010-09-09 よつ葉乳業株式会社 シアル酸化合物含有組成物の製造方法
MY183602A (en) 2008-12-19 2021-03-02 Chr Hansen Hmo Gmbh Synthesis of fucosylated compounds
GB0904562D0 (en) * 2009-03-17 2009-04-29 Separation Technologies Invest Isolation and purification of components of whey
KR20120022875A (ko) * 2009-04-07 2012-03-12 글리콤 에이/에스 ２'-ｏ-푸코실락토오스의 합성
DK2440661T3 (en) 2009-06-08 2018-03-12 Jennewein Biotechnologie Gmbh HMO synthesis
JP2012532195A (ja) * 2009-07-06 2012-12-13 チルドレンズ ホスピタル メディカル センター 乳オリゴ糖による炎症の阻害
IT1395068B1 (it) 2009-08-07 2012-09-05 Inalco Spa Processo per la produzione di galatto-oligosaccaridi ultrapuri
CN101691538B (zh) 2009-09-29 2012-05-09 保龄宝生物股份有限公司 一种米曲霉菌种及其制备高纯度低聚半乳糖的方法
CA2786710C (en) * 2010-01-19 2018-10-09 Abbott Laboratories Nutritional formulas containing synbiotics
WO2013096420A1 (en) 2011-12-19 2013-06-27 The Coca-Cola Company Methods for purifying steviol glycosides and uses of the same
US8889637B2 (en) 2010-06-01 2014-11-18 Glycom A/S Polymorphs of 2′-O-fucosyllactose and producing thereof
DK2944690T3 (en) 2010-10-11 2018-04-03 Jennewein Biotechnologie Gmbh UNKNOWN FUCOSYL TRANSFERASES AND THEIR APPLICATIONS
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
CN102154163A (zh) 2010-12-31 2011-08-17 朱莉 一种3′-唾液酸乳糖的制备方法
SG191792A1 (en) 2010-12-31 2013-08-30 Abbott Lab Human milk oligosaccharides for modulating inflammation
TW201233340A (en) * 2010-12-31 2012-08-16 Abbott Lab Human milk oligosaccharides for modulating inflammation
CA2822500C (en) * 2010-12-31 2022-07-26 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
EP2479263B1 (en) * 2011-01-20 2013-11-27 Jennewein Biotechnologie GmbH Novel Fucosyltransferases and their applications
CA2827313C (en) * 2011-02-16 2023-08-22 Glycosyn LLC Biosynthesis of human milk oligosaccharides in engineered bacteria
CN102095181A (zh) 2011-03-16 2011-06-15 黎昌兴 Led强光源流体巡回散热装置
JP6129821B2 (ja) * 2011-05-13 2017-05-17 グリコシン リミテッド ライアビリティー カンパニー プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
EP2526784A1 (en) 2011-05-24 2012-11-28 Nestec S.A. Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
DK2722394T3 (en) * 2011-06-07 2018-06-18 Hero Ag OBJECTIVES OF OLIGOSACCHARIDES BY A BIOTECHNOLOGICAL PROCEDURE
NL2007268C2 (en) * 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
JP6017133B2 (ja) * 2011-12-12 2016-10-26 Ｍｃフードスペシャリティーズ株式会社 風味改良剤
EP2828275B1 (en) 2012-03-20 2017-03-01 Glycom A/S Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
WO2013182206A1 (en) 2012-06-08 2013-12-12 Glycom A/S Method for producing oligosaccharides and oligosaccharide glycosides by fermentation
EP2861609A4 (en) 2012-06-14 2015-11-04 Glycom As IMPROVING STABILITY AND PURITY AND INCREASING THE BIOAVAILABILITY OF HUMAN MILK OLIGOSACCHARIDES OR PRECURSORS OR MIXTURES THEREOF
ITFI20120143A1 (it) * 2012-07-12 2014-01-13 Inalco S A S Di Giovanni Cipollett I & C Polimorfi idrati e anidri del 2'-o-fucosillattosio e loro metodi di produzione.
US9029136B2 (en) 2012-07-25 2015-05-12 Glycosyn LLC Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides
WO2014086373A1 (en) 2012-12-07 2014-06-12 Glycom A/S Crystallisation of human milk oligosaccharides (hmo)
PL2845905T3 (pl) 2013-09-10 2021-09-27 Chr. Hansen HMO GmbH Wytwarzanie oligosacharydów
CN103468766B (zh) 2013-09-18 2015-07-01 恩施天天佳生物科技有限公司 一种高纯度甘露低聚糖的制备方法
EP2857410A1 (en) 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
ES2701163T3 (es) * 2014-01-20 2019-02-21 Jennewein Biotechnologie Gmbh Procedimiento para la purificación eficiente de oligosacáridos de la leche humana (HMO) neutros a partir de la fermentación microbiana
EP3461890B1 (en) 2014-03-31 2025-09-24 Chr. Hansen HMO GmbH Total fermentation of oligosaccharides
MA39835A (fr) 2014-04-17 2017-02-22 Biogen Ma Inc Compositions et procédés de modulation de l'épissage du smn2 chez un patient
ES2968677T3 (es) 2014-06-11 2024-05-13 Glycom As Separación de 2’-O-fucosil-lactosa de caldo de fermentación
EP3141610A1 (en) 2015-09-12 2017-03-15 Jennewein Biotechnologie GmbH Production of human milk oligosaccharides in microbial hosts with engineered import / export

Also Published As

Publication number Publication date
DK201900072U1 (en) 2019-09-27
DK3680249T3 (da) 2023-04-24
CN106132977B (zh) 2020-05-12
CZ35288U1 (cs) 2021-08-03
EP3680249A2 (en) 2020-07-15
JP7000396B2 (ja) 2022-02-10
MX394692B (es) 2025-03-24
KR20160132009A (ko) 2016-11-16
ES2942586T3 (es) 2023-06-02
US20200231618A1 (en) 2020-07-23
FI3680249T3 (fi) 2023-04-25
MX369375B (es) 2019-11-07
WO2015106943A1 (en) 2015-07-23
DK2896628T3 (en) 2019-01-14
AT17271U1 (de) 2021-10-15
US11661435B2 (en) 2023-05-30
DK3131912T3 (da) 2020-02-10
EP3686211A2 (en) 2020-07-29
PL3131912T3 (pl) 2020-06-15
JP6901857B2 (ja) 2021-07-14
RU2016128955A (ru) 2018-02-26
EP3131912B1 (en) 2020-01-22
JP2020014482A (ja) 2020-01-30
EP3131912A1 (en) 2017-02-22
EP3686211A3 (en) 2021-01-20
AT17418U1 (de) 2022-03-15
US20190177352A1 (en) 2019-06-13
DK3686211T3 (da) 2023-04-24
US20210061836A1 (en) 2021-03-04
BR112016016705A8 (pt) 2022-10-11
CZ35289U1 (cs) 2021-08-03
US10882880B2 (en) 2021-01-05
MX2016009394A (es) 2017-02-08
RU2016128955A3 (es) 2018-05-21
ES2942630T3 (es) 2023-06-05
US20160333042A1 (en) 2016-11-17
RU2682445C2 (ru) 2019-03-19
EP3680249B1 (en) 2023-03-01
PL3680249T3 (pl) 2023-05-15
CN106132977A (zh) 2016-11-16
DE202014011399U1 (de) 2020-02-12
EP2896628B1 (en) 2018-09-19
EP3375786A1 (en) 2018-09-19
US11597740B2 (en) 2023-03-07
PH12016501421A1 (en) 2016-08-22
AU2014377374B2 (en) 2019-07-04
EP3680249A3 (en) 2021-01-20
DE202014011358U1 (de) 2019-09-26
EP3686211B1 (en) 2023-03-01
JP2017506065A (ja) 2017-03-02
US10377787B2 (en) 2019-08-13
PH12016501421B1 (en) 2016-08-22
PL2896628T3 (pl) 2019-03-29
DK201900054Y4 (da) 2019-09-26
FI3686211T3 (fi) 2023-04-26
AU2014377374A1 (en) 2016-08-04
ES2701163T3 (es) 2019-02-21
PL3686211T3 (pl) 2023-06-05
KR102137027B1 (ko) 2020-07-23
BR112016016705A2 (es) 2017-08-08
DK201900054U1 (en) 2019-07-02
ES2779414T3 (es) 2020-08-17
PH12020500199A1 (en) 2021-03-15
EP2896628A1 (en) 2015-07-22

Similar Documents

Publication Publication Date Title
MX2019013267A (es) Proceso para una purificacion eficaz de oligosacaridos de leche humana (olh) neutros a partir de fermentacion microbiana.
CO2021007995A2 (es) Compuestos de heterociclil piridazina como fungicidas
MX390064B (es) Formas cristalinas de mononucleotido de beta-nicotinamida.
BR112019002357A2 (pt) purificação de matéria-prima por tratamento térmico
AR104523A1 (es) Planta y método modular para la producción y/o tratamiento continuo de productos estériles
AR090319A1 (es) Biorrefineria integrada
MX2017002765A (es) Il-23a y tnf-alfa orientados y compuesto y sus usos.
CO2017001884A2 (es) Polimorfos de selinexor
CU24603B1 (es) Imidazopirimidinas diazabicíclicas sustituidas útiles en el tratamiento de trastornos respiratorios
CR20150448A (es) Pirimidinas fusionadas sustituidas con trifluorometilo y sus usos
UY37035A (es) MOLÉCULAS DE ANTICUERPO MULTIESPECÍFICO CON ESPECIFICIDAD POR TNF-ALFA, IL-17A e IL-17F
EP3510140A4 (en) NEW CULTURE SYSTEM FOR EFFICIENT PRODUCTION OF MICROORGANISMS
EP3978102A4 (en) Forward osmosis membrane, forward osmosis membrane module, and manufacturing method thereof
GB2549433A (en) Aysmmetric composite memebranes and modified substrates used in their preparation
MX2017013974A (es) Fabricacion de productos lacteos fermentados concentrados.
LT3400225T (lt) Pirolo-[2-3,b]pirimidin-piridinais pakeistos pentanoinės rūgštys gripo virusinės infekcijos gydymui
BR112017001177A2 (pt) processo para a purificação de poliovírus a partir de culturas celulares
MX376475B (es) Derivado de polimixina y usos del mismo.
EP3359272A4 (en) HOLLOW FIBER MEMBRANE MODULE COMPRISING A CONCENTRATE DISPENSER
UY36851A (es) Compuestos para uso en aplicaciones antibacterianas
AR100131A1 (es) Proceso de purificación de gonadotropina
BR112016023415A8 (pt) membrana de filtração e seu método de produção, polímero e método para purificação de água
AR105964A1 (es) Procedimiento autosuficiente para la producción de hidrolizado de biomasa con contenido en sal reducido
AR101442A1 (es) Método para la expansión de células madre de adultos de sangre
CL2018003739A1 (es) Formas cristalinas de un compuesto de tetraciclina sustituida con 9-aminometilo y un método para su preparación.